Radboud University Nijmegen

Running trials

• Not yet recruiting

  Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy

  NCT06647602· Source

• Recruiting

  Pharmacologically modulating the noradrenergic arousal system to reduce freezing of gait in Parkinson’s disease: a multi-center and multi-modal approach.

  2024-516756-18-00· Phase 3· Source

• Active, not recruiting

  A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy

  NCT06713135· Phase 4· Source

• Recruiting

  Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)

  NCT07265596· Phase 2· Source

• Active, not recruiting

  Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F

  NCT04765345· Source

• Recruiting

  PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  NCT04477785· Source

• Active, not recruiting

  Rate of Progression in EYS Related Retinal Degeneration

  NCT04127006· Source

• Recruiting

  Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose

  NCT04073290· Phase 4· Source

• Active, not recruiting

  Rate of Progression in USH2A-related Retinal Degeneration

  NCT03146078· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Parkinson disease3 recruiting
• High blood pressure1 recruiting
• Thyroid cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer

  NCT04487847· Phase 1/2· Source

• Completed

  Study of DF1001 in Patients With Advanced Solid Tumors

  NCT04143711· Phase 1/2· Source

Trial sites

• Radboud Universiteit Nijmegen1 trial
• Radboud University7 trials
• Radboud University Nijmegen3 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Parkinson disease95 works · 3 trials
• Depression39 works · 0 trials
• Systemic sclerosis (scleroderma)18 works · 0 trials